VISN 5 MIRECC - General Publications 2008
About Us • Clinical • Education • Research
VISN 5 MIRECC home
Bellack, A.S. (2008). Psychosocial rehabilitation. In A. Tasman, J.A., Lieberman, M.B. First, & M. Maj (Eds), Psychiatry (Third ed). New York: John Wiley & Sons.
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008). Galantamine for the treatment of cognitive impairments in patients with schizophrenia. American Journal of Psychiatry, 165(1), 82-89.
Carpenter, W. T. (2008). More changes for the Schizophrenia Bulletin [editorial]. Schizophrenia Bulletin, 34(1), 1-2.
Carpenter, W. T., & Buchanan, R. W. (2008). Lessons to take home from CATIE. Psychiatric Services, 59(5), 523-525.
Carpenter, W. T., & Koenig, J. I. (2008). The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology, 33, 2061-2079.
Chinman, M., Lucksted, A., Gresen, R., Davis, M., Losonczy, M., Sussner, B., & Martone, L. (2008). Early experiences of consumer providers in the VA. Psychiatric Services, 59(11), 1315-1321.
Cohen, A. N., Glynn, S. M., Murray-Swank, A. B., Barrio, C., Fischer, E. P., McCutcheon, S. J., Perlick, D. A., Rotondi, A. J., Sayers, S. L., Sherman, M. D., & Dixon, L. B. (2008). The family forum: present and future directions in the implementation and dissemination of family psychoeducation. Psychiatric Services, 59, 40-48.
Cook, J., Blyler, C., Burke-Miller, J., McFarlane, W., Leff, H. S., Mueser, K., Gold, P., Goldberg, R., Shafer, M., Onken, S., Donegan, K., Carey, M. A., Razzano, L., Grey, D., Pickett-Schenk, S., & Kaufmann, C. (2008). Effectiveness of supported employment for individuals with schizophrenia: results of a multi-site, randomized trial. Clinical Schizophrenia and Related Psychoses, 2(1), 37-46.
Deutsch, S. I., Rosse, R. B., Connor, J. M., Burket, J. A., Murphy, M. E., & Fox, F. J. (2008). Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with multiple sclerosis, complex vocal tics, paroxysmal dystonia and marijuana dependence treated with dronabinol. CNS Spectrums, 13(5), 393-403.
Deutsch, S. I., Rosse, R. B., Long, K. D., Gaskins, B. L., Burket, J. A., & Mastropaolo, J. (2008). Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801’s pharmacologic action. European Neuropsychopharmacology, 18, 565-568.
Deutsch, S. I., Rosse, R. B., Long, K. D., Gaskins, B. L., & Mastropaolo, J. (2008). Guanosine possesses specific modulatory effects on NMDA receptor-mediated neurotransmission in intact mice. European Neuropsychopharmacology, 18, 299-302.
Deutsch, S. I., Rosse, R. B., Mastropaolo, J., Long, K. D., & Gaskins, B. L. (2008). Epigenetic therapeutic strategies of neuropsychiatric disorders: ready for prime time? Clinical Neuropharmacology, 31(2), 104-119.
Deutsch, S. I., Schwartz, B. L., Schooler, N. R., Rosse, R. B., Mastropaolo, J., & Gaskins, B. (2008). First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy. Clinical Neuropharmacology, 31(1), 34-39.
Dickerson, F., Brown, C. H., Fang, L., Goldberg, R. W., Kreyenbuhl, J., Wohlheiter, K., & Dixon, L., (2008). Quality of life in individuals with serious mental illness and Type 2 Diabetes. Psychosomatics, 49(2), 109-114.
Dickinson, D. (2008). Digit symbol coding and general cognitive ability in schizophrenia: worth another look? British Journal of Psychiatry, 193(5), 354-356.
Dickinson, D., & Gold, J. M. (2008). Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin, 34(3), 423-434.
Dickinson, D., Gold, J. M., Dickerson, F. B., Medoff, D., & Dixon, L. B. (2008). Evidence of exacerbated cognitive deficits in schizophrenia patients with co-morbid diabetes. Psychosomatics, 49(2), 123-131.
Dickinson, D., & Harvey, P. D. (2008). Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophrenia Bulletin. Aug 9, 2008. [Epub ahead of print]
Dickinson, D., Ragland, J. D., Gold, J. M., & Gur, R. C. (2008). General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biological Psychiatry. May 8. [Epub ahead of print].
DiClemente, C. C., Nidecker, M., & Bellack, A.S. (2008). Motivation and the stages of change among individuals with co-occurring disorders. Journal of Substance Abuse Treatment, 34, 25-35.
Drapalski, A., Milford, J., Goldberg, R., Brown, C. W., & Dixon, L. (2008). Perceived barriers to medical and mental health care among veterans with serious mental illness. Psychiatric Services, 59, 921-924
Drapalski, A. L., Marshall, T., Seybolt, D., Medoff, D., Peer, J., Leith, J., & Dixon, L. B. (2008). The unmet needs of families of individuals with mental illness and preferences regarding family services. Psychiatric Services, 59(6), 655-662.
Glynn, S., Dixon, L., Cohen, A., & Murray-Swank, A. (2008). The family member provider outreach program: an innovative way to engage family members in mental health care. Psychiatric Services, 59, 934.
Gold, J. M., Waltz, J. A., Prentice, K. J., Morris, S. E., & Heerey, E. A. (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophrenia Bulletin, 34, 835-847.
Goldberg, R, Hackman, A., Medoff, D., Brown, C., Dickerson, F., Fang, L., Kreyenbuhl, J., & Dixon, L. (2008). Physical wellness and employment status and adults with serious mental illness. Community Mental Health Journal, 44(4), 245-251.
Goldberg, R., & Seth, P. (2008). Hepatitis C services and individuals with serious mental illness. Community Mental Health Journal, 44(5), 381-84.
Green, M. F, Penn, D. L., Bentall, R., Carpenter, W. T., Gaebel, W., Gur, R. C., Kring, A. M., Park, S., Silverstein, S. M., & Heinssen, R. (2008). Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin. Advance Access published on January 8, 2008. doi:10.1093/schbul/sbm145
Hong, L. E., Turano, K. A., O’Neill, H., Hao, L., Wonodi, I., Elliott, A., & Thaker, G. K. (2008). Refining the predictive pursuit endophenotype in schizophrenia. Biological Psychiatry, 63(5), 458-464.
Hong, L. E., Wonodi, I. O., Stine, C., Mitchell, B. D., & Thaker, G. K. (2008). Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biological Psychiatry, 63(1), 17-23.
Kelly, D. L., McMahon, R. P., Weiner, E., Boggs, D. L., Dickinson, D., Conley, R. R., & Buchanan, R. W. (2008). Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophrenia Research, 103, 161-168.
Kemp, A. S., Schooler, N. R., Kalali, A. H., Alphs, L., Anand, R., Awad, G., Davidson, M., Dube, S., Ereshefsky, L., Gharabawi, G., Leon, A. C., Lepine, J. P., Potkin, S., & Vermeulen, A. (2008). What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophrenia Bulletin. August 22. [Epub ahead of print].
Kreyenbuhl, J., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., & Valenstein, M. (2008). Does adherence to medications for Type 2 diabetes differ between individuals with versus without schizophrenia? Schizophrenia Bulletin. Aug 20, 2008. [E-pub ahead of print]
Kreyenbuhl, J., Medoff, D. R., Seliger, S. L., & Dixon, L. B. (2008). Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes. Schizophrenia Research, 101, 256-265.
Lucksted, A., Stewart, B., Dixon, L. B., & Forbes, C. (2008). Benefits and changes for family to family graduates. American Journal of Community Psychology, 42, 154-166.
McMahon, R. P., Kelly, D. L., Boggs, D. L., Li, L., Hu, Q., Davis, J. M., & Carpenter, W. T. (2008). Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research. Schizophrenia Bulletin, 34(2), 292-301.
Morris, S. E., Heerey, E. A., Gold, J. M., & Holroyd, C. B. (2008). Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophrenia Research, 99(1-3), 274-285.
Nidecker, M. F., DiClemente, C. C., Bennett, M. E., & Bellack, A. S. (2008). Application of the Transtheoretical Model of Change: Psychometric properties of leading measures in patients with co-occurring drug abuse and severe mental illness. Addictive Behaviors, 33, 1021-1030.
Peer, J., Strachan, E., & Spaulding, W. (2008). Heterogeneity in behavioral treatment response in severe mental illness. Journal of Nervous and Mental Disease, 196, 198-206.
Perera, P. Y., Lichy, J. H., Mastropaolo, J., Rosse, R. B., & Deutsch, S. I. (2008). Expression of NR1, NR2A, and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist. European Neuropsychopharmacology, 18(11), 814-819.
Salkever, D. S., Johnston, S., Karakus, M., Ialongo, N., Slade, E. P., & Stuart, E. A. (2008). Enhancing the net benefits of disseminating new prevention programs: a note on target efficiency with illustrative examples. Administration and Policy in Mental Health and Mental Health Services Research. March 15. [Epub ahead of print].
Silverstein, S. M., & Bellack, A. S. (2008). A Scientific Agenda for the Concept of Recovery as it Applies to Schizophrenia. Clinical Psychology Review, 28, 1108-1124.
Slade, E. P., Stuart, E. A., Salkever, D. S., Karakus, M., Green, K., & Ialongo, N. (2008). Impacts of age on onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: a propensity score matching approach. Drug and Alcohol Dependence, 95(1-2), 1-13.
Smelson, D. A., Dixon, L., Craig, T., Remolina, S., Batki, S., Niv, N., & Owen, R. (2008). Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS Drugs, 22(11), 903-916.
Tenhula, W. N., & Bellack, A. S. (2008). Social skills training. In K. T. Mueser & D. V. Jeste (Eds), Clinical handbook of schizophrenia. New York: Guilford Press.
Tenhula, W. N., Bellack, A. S., & Drake, R. E. (2008). Schizophrenia: psychosocial approaches. In B. J. Sadock & V. A. Saddock (Eds.), Kaplan & Sadock’s Comprehensive textbook of psychiatry (3rd Edition). Baltimore: Lippincott, Williams, & Wilkins.
Thaker, G. (2008). Psychosis endophenotypes in schizophrenia and bipolar disorder. Schizophrenia Bulletin, 34(4), 720-721.
Thaker, G. K. (2008). Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophrenia Bulletin, 34(4), 760-773.
Wonodi, I., Hong, L. E., & Thaker, G. K. (2008). Molecular Pathology. In G. K. Thaker & W. T. Carpenter, The Year in Schizophrenia (Vol. 2). Portland: Book News, Inc.
Zhu, B., Ascher-Svanum, H., Faries, D. E., Peng, X., Salkever, D., & Slade, E. P. (2008). Costs of treating patients with schizophrenia who have illness-related crisis events. BMC Psychiatry, 8(72). DOI:10.1186/1471-244X-8-72 2008.
NOTE: Names in bold are VISN 5 MIRECC Investigators
